Original Research
Published on 17 Feb 2022
CCL5 as a Prognostic Marker for Survival and an Indicator for Immune Checkpoint Therapies in Small Cell Lung Cancer
in Pathology
- 4,002 views
- 14 citations
Original Research
Published on 17 Feb 2022
in Pathology
Original Research
Published on 14 Feb 2022
in Pathology
Editorial
Published on 11 Feb 2022
in Pathology
Brief Research Report
Published on 10 Feb 2022
in Pathology
Original Research
Published on 09 Feb 2022
in Pathology
Case Report
Published on 07 Feb 2022
in Pathology
Original Research
Published on 27 Jan 2022
in Pathology
Original Research
Published on 24 Jan 2022
in Pathology
Case Report
Published on 24 Jan 2022
in Pathology
Review
Published on 10 Jan 2022
in Pathology
Case Report
Published on 10 Jan 2022
in Pathology
Original Research
Published on 28 Dec 2021
in Pathology
Original Research
Published on 16 Dec 2021
in Pathology
Original Research
Published on 15 Dec 2021
in Pathology
Original Research
Published on 15 Dec 2021
in Pathology
Case Report
Published on 29 Nov 2021
in Pathology